Biogen Earnings Crush Forecasts: But Pay Attention To Multiple Sclerosis, Spinraza Investor’s Business Daily
Biogen stock rose Tuesday after Biogen earnings and sales beat views. The biotech company also topped forecasts for sales of multiple sclerosis treatments.
